The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Open accessAbstract
Inflammation occurs as a result of exposure of tissues and organs to harmful stimuli such as microbial pathogens, irritants, or toxic cellular components. The primary physical manifestations of inflammation are redness, swelling, heat, pain, and loss of function to the affected area. These processes involve the major cells of the immune system, including monocytes, macrophages, neutrophils, basophils, dendritic cells, mast cells, T-cells, and B-cells. However, examination of a range of inflammatory lesions demonstrates the presence of specific leukocytes in any given lesion. That is, the inflammatory process is regulated in such a way as to ensure that the appropriate leukocytes are recruited. These events are in turn controlled by a host of extracellular molecular regulators, including members of the cytokine and chemokine families that mediate both immune cell recruitment and complex intracellular signalling control mechanisms that characterise inflammation. This review will focus on the role of the main cytokines, chemokines, and their receptors in the pathophysiology of auto-inflammatory disorders, pro-inflammatory disorders, and neurological disorders involving inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D., Sauter, N. S., Ellingsgaard, H., Bosco, D., Baertschiger, R. M., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 179
RetractedAn endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 1×
“This can then lead to the induction of IL-1β expression [7,8].”
BackgroundThe TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 1×
“The discovery and cloning of BSF-2 in 1986 [49] was followed by recognition of the fact that these diverse activities were due to a single cytokine, renamed IL-6 [45].”
BackgroundTNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,887
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Goekoop‐Ruiterman, Y. P. M., De Vries‐Bouwstra, J. K., Allaart, C. F., Van Zeben, D., Kerstens, P. J. S. M., Hazes, J. M. W., Zwinderman, A. H., Ronday, H. K., Han, K. H., Westedt, M. L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21405 · Cited by 1,460
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,325
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Experimental models of inflammatory bowel disease
Elson, C. O., Sartor, R. B., Tennyson, G. S., & Riddell, R. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90599-5 · Cited by 1,212
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Neutrophil granules and secretory vesicles in inflammation
Faurschou, M., & Borregaard, N. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.09.008 · Cited by 1,162 · cited 1×
“Neutrophil granules contain several effector molecules, such as the antimicrobial proteins myeloperoxidase, defensins and lysozyme [83].”
BackgroundThe NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Tartaglia, L. A., & Goeddel, D. V. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90116-o · Cited by 1,035
Natural History and Outcome in Systemic AA Amyloidosis
Lachmann, H. J., Goodman, H. J. B., Gilbertson, J. A., Gallimore, J. R., Sabin, C. A., Gillmore, J. D., & Hawkins, P. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070265 · Cited by 1,032
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Tedgård, U., Cowen, E. W., Pham, T.-H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 987
Self-citationNeonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Self-citationHuman tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 921
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869
Chemokines: multiple levels of leukocyte migration control☆
Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.005 · Cited by 860
A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 1×
“The presence of activated microglial cells and elevated levels of several pro-inflammatory cytokines are evident in post-mortem examinations of the SN [256,257].”
BackgroundDu, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Roach, D. R., Bean, A. G. D., Demangel, C., France, M. P., Briscoe, H., & Britton, W. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4620 · Cited by 782
Feldmann, J., Prieur, A.-M., Quartier, P., Berquin, P., Certain, S., Cortis, E., Teillac-Hamel, D., Fischer, A., & Basile, G. D. S. (2002) · The American Journal of Human Genetics · doi:10.1086/341357 · Cited by 743
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation
Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B., & Mohler, K. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.943 · Cited by 706
Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome
Hawkins, P. N., Lachmann, H. J., & McDermott, M. F. (2003) · New England Journal of Medicine · doi:10.1056/nejm200306193482523 · Cited by 654
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649
Lymphotactin: a Cytokine that Represents a New Class of Chemokine
Kelner, G. S., Kennedy, J., Bacon, K. B., Kleyensteuber, S., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Bazan, J. F., Moore, K. W., Schall, T. J., et al. (1994) · Science · doi:10.1126/science.7973732 · Cited by 648
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
The cholinergic anti-inflammatory pathway
Pavlov, V. A., & Tracey, K. J. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.015 · Cited by 622
Dancing to the tune of chemokines
Thelen, M. (2001) · Nature Immunology · doi:10.1038/84224 · Cited by 618
The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress
O'Neill, L. A. J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00701.x · Cited by 616
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
TNF receptor subtype signalling: Differences and cellular consequences
MacEwan, D. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00262-5 · Cited by 610
Roles for NF-κB in nerve cell survival, plasticity, and disease
Mattson, M. P., & Meffert, M. K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401837 · Cited by 595
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584
Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 584
Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 583
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides
Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571
Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P., Wanderer, A. A., & Firestein, G. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17401-1 · Cited by 552
Chemokines Trigger Immediate β2 Integrin Affinity and Mobility Changes
Constantin, G., Majeed, M., Giagulli, C., Piccio, L., Kim, J. Y., Butcher, E. C., & Laudanna, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00074-1 · Cited by 521
Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.
Mukaida, N., Shiroo, M., & Matsushima, K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1366 · Cited by 507
Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease
Nagele, R. G., Wegiel, J., Venkataraman, V., Imaki, H., Wang, K.-C., & Wegiel, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.007 · Cited by 504
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lügering, N., Domschke, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208231200 · Cited by 476
Miller, E. J., Cohen, A. B., Nagao, S., Griffith, D., Maunder, R. J., Martin, T. R., Weiner-Kronish, J. P., Sticherling, M., Christophers, E., & Matthay, M. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.427 · Cited by 472
Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease
Sparks Stein, P., Steffen, M. J., Smith, C., Jicha, G., Ebersole, J. L., Abner, E., & Dawson, D. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.04.006 · Cited by 463
HULL, K. M., DREWE, E., AKSENTIJEVICH, I., SINGH, H. K., WONG, K., MCDERMOTT, E. M., DEAN, J., POWELL, R. J., & KASTNER, D. L. (2002) · Medicine · doi:10.1097/00005792-200209000-00002 · Cited by 455
The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453
Minocycline and Neurodegenerative Diseases
Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Ghosh, A., Roy, A., Liu, X., Kordower, J. H., Mufson, E. J., Hartley, D. M., Ghosh, S., Mosley, R. L., Gendelman, H. E., & Pahan, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704908104 · Cited by 438
Shedding of tumor necrosis factor receptors by activated human neutrophils.
Porteu, F., & Nathan, C. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.599 · Cited by 437
Groom, J. R., Richmond, J., Murooka, T. T., Sorensen, E. W., Sung, J. H., Bankert, K., von Andrian, U. H., Moon, J. J., Mempel, T. R., & Luster, A. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.016 · Cited by 433
Prevention of Constitutive TNF Receptor 1 Signaling by Silencer of Death Domains
Jiang, Y., Woronicz, J. D., Liu, W., & Goeddel, D. V. (1999) · Science · doi:10.1126/science.283.5401.543 · Cited by 417
Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains
Nagele, R. G., D’Andrea, M. R., Lee, H., Venkataraman, V., & Wang, H.-Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02361-8 · Cited by 416
Virus interference. II. Some properties of interferon
Isaacs, A., Lindenmann, J., & Valentine, R. C. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0049 · Cited by 413
Ying, S., Meng, Q., Zeibecoglou, K., Robinson, D. S., Macfarlane, A., Humbert, M., & Kay, A. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6321 · Cited by 411
The role of astroglia in neuroprotection
Bélanger, M., & Magistretti, P. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/mbelanger · Cited by 396
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function
James, L. C., Keeble, A. H., Khan, Z., Rhodes, D. A., & Trowsdale, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609174104 · Cited by 386 · cited 1×
“The Mefv gene product, pyrin, is a member of the tripartite motif family (TRIM20) with a conserved C-terminal PRYSPRY domain in which several of the common mutations observed in FMF are located [114].”
BackgroundBreidert, T., Callebert, J., Heneka, M. T., Landreth, G., Launay, J. M., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00990.x · Cited by 373
Zhao, J., O'Connor, T., & Vassar, R. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-150 · Cited by 369
IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors
Hammond, M. E., Lapointe, G. R., Feucht, P. H., Hilt, S., Gallegos, C. A., Gordon, C. A., Giedlin, M. A., Mullenbach, G., & Tekamp-Olson, P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1428 · Cited by 367
Casanova, J.-L., Abel, L., & Quintana-Murci, L. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101335 · Cited by 366
Flier, J., Boorsma, D. M., van Beek, P. J., Nieboer, C., Stoof, T. J., Willemze, R., & Tensen, C. P. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200108)194:4<397::aid-path899>3.0.co;2-s · Cited by 363
Nitrated α–Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Pisarev, V. M., Tsiperson, V., Nemachek, C., Ciborowski, P., Przedborski, S., Mosley, R. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001376 · Cited by 362
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Economides, A. N., Carpenter, L. R., Rudge, J. S., Wong, V., Koehler-Stec, E. M., Hartnett, C., Pyles, E. A., Xu, X., Daly, T. J., Young, M. R., et al. (2003) · Nature Medicine · doi:10.1038/nm811 · Cited by 359
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., Oostingh, G. J., Pfaller, T., Pixner, C., Posselt, G., et al. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0288 · Cited by 357
Interleukin-1, neuroinflammation, and Alzheimer's disease
Mrak, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00287-1 · Cited by 356
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1504-06.2006 · Cited by 354
He, Y., Appel, S., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 348
Pruenster, M., Mudde, L., Bombosi, P., Dimitrova, S., Zsak, M., Middleton, J., Richmond, A., Graham, G. J., Segerer, S., Nibbs, R. J. B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1675 · Cited by 339
C-reactive protein and the biology of disease
Ansar, W., & Ghosh, S. (2013) · Immunologic Research · doi:10.1007/s12026-013-8384-0 · Cited by 336
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Self-citationStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Kryczek, I., Wei, S., Keller, E., Liu, R., & Zou, W. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2006 · Cited by 329
Anti-Inflammatory Treatments for Chronic Diseases: A Review
Laveti, D., Kumar, M., Hemalatha, R., Sistla, R., Naidu, V., Talla, V., Verma, V., Kaur, N., & Nagpal, R. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/18715281113129990053 · Cited by 325
Loetscher, P., Seitz, M., Lewis, I. C., Baggiolini, M., & Moser, B. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.13.7926371 · Cited by 323
Johnstone, M., Gearing, A. J. H., & Miller, K. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00226-4 · Cited by 313
Cytokines in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6284-2_12 · Cited by 308
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303
Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02970-x · Cited by 300
Neuroinflammatory processes in Parkinson's disease
Hirsch, E. C., Hunot, S., & Hartmann, A. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.10.013 · Cited by 296
Signaling via NF-κB in the nervous system
Kaltschmidt, B., Widera, D., & Kaltschmidt, C. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.05.009 · Cited by 293
Kohutnicka, M., Lewandowska, E., Kurkowska-Jastrzębska, I., Członkowski, A., & Członkowska, A. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00022-8 · Cited by 283
Huang, H.-C., & Jiang, Z.-F. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0960 · Cited by 279
Aggresome‐related biogenesis of Lewy bodies
McNaught, K. S. P., Shashidharan, P., Perl, D. P., Jenner, P., & Olanow, C. W. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02301.x · Cited by 279
Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis
Peters, M., Müller, A. M., & Rose-John, S. (1998) · Blood · doi:10.1182/blood.v92.10.3495 · Cited by 276
Lindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.007 · Cited by 276
Le, W.-D., Rowe, D., Xie, W., Ortiz, I., He, Y., & Appel, S. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08447.2001 · Cited by 275
Lossinsky, A. S., & Shivers, R. R. (2004) · PubMed · doi:10.14670/hh-19.535 · Cited by 272
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
NF-κB in the Survival and Plasticity of Neurons
Mattson, M. P. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6961-x · Cited by 254
Changes of the cytokine profile in inflammatory bowel diseases
Műzes, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i41.5848 · Cited by 250
Pope, S. M., Zimmermann, N., Stringer, K. F., Karow, M. L., & Rothenberg, M. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5341 · Cited by 250
Iravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247
Neurobiology and treatment of Parkinson's disease
Schapira, A. H. V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.005 · Cited by 247
Acute phase response in familial Mediterranean fever
Korkmaz, C., Özdogan, H., Kasapçopur, Ö., & Yazici, H. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.1.79 · Cited by 242
Human Cytokines: Their Role in Disease and Therapy
Greening, A. P. (1995) · BMJ · doi:10.1136/bmj.311.7020.1649a · Cited by 242
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 238
Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Medoff, B. D., Sauty, A., Tager, A. M., Maclean, J. A., Smith, R. N., Mathew, A., Dufour, J. H., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5278 · Cited by 231
Goldbach‐Mansky, R., Shroff, S. D., Wilson, M., Snyder, C., Plehn, S., Barham, B., Pham, T., Pucino, F., Wesley, R. A., Papadopoulos, J. H., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23620 · Cited by 229
Sánchez‐Pernaute, R., Ferree, A. W., Cooper, O., Yu, M., Brownell, A., & Ole Isacson, A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-6 · Cited by 229
Cytokine production by islets in health and diabetes: cellular origin, regulation and function
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., Halban, P. A., & Ehses, J. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.12.010 · Cited by 227
Inflammation: A new candidate in modulating adult neurogenesis
Das, S., & Basu, A. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21585 · Cited by 226
Suk, K., Kim, S., Kim, Y.-H., Kim, K.-A., Chang, I., Yagita, H., Shong, M., & Lee, M.-S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4481 · Cited by 223
Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., & Rivest, S. (2008) · Brain · doi:10.1093/brain/awn331 · Cited by 221
The role of cytokines in the pathogenesis of inflammatory eye disease
WAKEFIELD, D. (1992) · Cytokine · doi:10.1016/1043-4666(92)90028-p · Cited by 217
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216 · cited 3×
“However there is also evidence that microglia can have neurotoxic effects in the brain [212], likely via the release of potent pro-inflammatory molecules [213] and other immunomodulatory molecules which lead to the recruitment of monocytes and lymphocytes through the blood-brain barrier (BBB) [214,215].”
BackgroundPobezinskaya, Y. L., Kim, Y.-S., Choksi, S., Morgan, M. J., Li, T., Liu, C., & Liu, Z. (2008) · Nature Immunology · doi:10.1038/ni.1639 · Cited by 216
Wang, M., Lin, W., Chen, H., Chang, Y., Ou, H., Kuo, J., Hong, J., & Jeng, K. G. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02290.x · Cited by 213
Neutrophil Attractant/Activation Protein-1 (NAP-1 [Interleukin-8])
Leonard, E. J., & Yoshimura, T. (1990) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/2.6.479 · Cited by 212
Liu, Y., Qin, L., Li, G., Zhang, W., An, L., Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043166 · Cited by 205
Mori, T., Koyama, N., Arendash, G. W., Horikoshi‐Sakuraba, Y., Tan, J., & Town, T. (2010) · Glia · doi:10.1002/glia.20924 · Cited by 205
Cytokine secretion in macrophages and other cells: Pathways and mediators
Stow, J. L., Ching Low, P., Offenhäuser, C., & Sangermani, D. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.005 · Cited by 205
Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments
Haneklaus, M., O’Neill, L. A., & Coll, R. C. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.004 · Cited by 204
Tomás-Camardiel, M., Rite, I., Herrera, A. J., de Pablos, R. M., Cano, J., Machado, A., & Venero, J. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.010 · Cited by 203
Friedmann, E., Hauben, E., Maylandt, K., Schleeger, S., Vreugde, S., Lichtenthaler, S. F., Kuhn, P.-H., Stauffer, D., Rovelli, G., & Martoglio, B. (2006) · Nature Cell Biology · doi:10.1038/ncb1440 · Cited by 201
Biological role of interleukin 1 receptor antagonist isoforms
Arend, W. P., & Guthridge, C. J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i60 · Cited by 201
Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis
Mahida, Y. R., Ceska, M., Effenberger, F., Kurlak, L., Lindley, I., & Hawkey, C. J. (1992) · Clinical Science · doi:10.1042/cs0820273 · Cited by 199
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
Shen, Y., Li, R., McGeer, E. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 195
Gonzalo, J.-A., Lloyd, C. M., Peled, A., Delaney, T., Coyle, A. J., & Gutierrez-Ramos, J.-C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.499 · Cited by 191
Deleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease
Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189
Arimoto, T., & Bing, G. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00017-7 · Cited by 189
Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A
Kawaguchi, Y., Hara, M., & Wright, T. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4304 · Cited by 187
Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction
de Haas, A. H., van Weering, H. R. J., de Jong, E. K., Boddeke, H. W. G. M., & Biber, K. P. H. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0036-8 · Cited by 182
Activation of host pattern recognition receptors by viruses
Brennan, K., & Bowie, A. G. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.007 · Cited by 178
IL-1 and T Helper Immune Responses
Santarlasci, V., Cosmi, L., Maggi, L., Liotta, F., & Annunziato, F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00182 · Cited by 176
Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease
Hasan, A., Fortune, F., Wilson, A., Warr, K., Lehner, T., Sanderson, J., Shinnick, T., Mizushima, Y., van der Zee, R., & Stanford, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90868-5 · Cited by 175
Yang, L., Calingasan, N. Y., Thomas, B., Chaturvedi, R. K., Kiaei, M., Wille, E. J., Liby, K. T., Williams, C., Royce, D., Risingsong, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005757 · Cited by 172
Mott, R. T., Ait‐Ghezala, G., Town, T., Mori, T., Vendrame, M., Zeng, J., Ehrhart, J., Mullan, M., & Tan, J. (2004) · Glia · doi:10.1002/glia.20009 · Cited by 170
Delgado, M., & Ganea, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-0799fje · Cited by 166
Nomiyama, H., Osada, N., & Yoshie, O. (2012) · Genes to Cells · doi:10.1111/gtc.12013 · Cited by 164
Tumor necrosis factor receptors-structure and function
Rothe, J., Gehr, G., Loetscher, H., & Lesslauer, W. (1992) · Immunologic Research · doi:10.1007/bf02918612 · Cited by 163
Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
Yang, L., Sugama, S., Chirichigno, J. W., Gregorio, J., Lorenzl, S., Shin, D. H., Browne, S. E., Shimizu, Y., Joh, T. H., Beal, M. F., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10709 · Cited by 158
Amyloid-β-induced chemokine production in primary human macrophages and astrocytes
Smits, H. A., Rijsmus, A., van Loon, J. H., Wat, J. W. Y., Verhoef, J., Boven, L. A., & Nottet, H. S. L. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00112-1 · Cited by 153
Macrophages and islet inflammation in type 2 diabetes
Eguchi, K., & Manabe, I. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12168 · Cited by 152
Miotto, D., Christodoulopoulos, P., Olivenstein, R., Taha, R. A., Cameron, L., Tsicopoulos, A., Tonnel, A., Fahy, O., Lafitte, J., Luster, A. D., et al. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113524 · Cited by 151
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
Jücker, M., Abts, H. F., Li, W., Schindler, R., Merz, H., Günther, A., Kalle, C. V., Schaadt, M., Diamantstein, T., & Feller, A. C. (1991) · Blood · doi:10.1182/blood.v77.11.2413.2413 · Cited by 149
Heneka, M. T., Wiesinger, H., Dumitrescu‐Ozimek, L., Riederer, P. F., Feinstein, D. L., & Klockgether, T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.906 · Cited by 148
α-Synuclein and Neuronal Cell Death
Yasuda, T., Nakata, Y., & Mochizuki, H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8327-0 · Cited by 145
Autoinflammatory Diseases: Clinical and Genetic Advances
Farasat, S., Aksentijevich, I. A., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.392 · Cited by 143
Interleukin-6 in the pathogenesis of rheumatoid arthritis.
Park, J. Y., & Pillinger, M. H. (2007) · PubMed · Cited by 143
Friedman, W. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7595 · Cited by 140
Reeves, B. C., Angelini, G. D., Bryan, A. J., Taylor, F. C., Cripps, T., Spyt, T. J., Samani, N. J., Roberts, J., Jacklin, P., Seehra, H. K., et al. (2004) · Health Technology Assessment · doi:10.3310/hta8160 · Cited by 140
Gauldie, J., Richards, C. D., Northemann, W., Fey, G. H., & Baumann, H. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb23998.x · Cited by 132
Transcriptional Factor NF- κ B as a Target for Therapy in Parkinson's Disease
Flood, P. M., Li, Q., Peterson, L. J., Zhang, F., Shi, J., Gao, H., & Hong, J. (2011) · Parkinson s Disease · doi:10.4061/2011/216298 · Cited by 129
Neuron-microglia signaling: Chemokines as versatile messengers
Biber, K. P. H., Vinet, J., & Boddeke, H. W. G. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.012 · Cited by 125
Arai, H., Furuya, T., Yasuda, T., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407328200 · Cited by 122
Monomeric and Dimeric CXCL8 Are Both Essential for In Vivo Neutrophil Recruitment
Das, S., Rajagopalan, L., Guerrero-Plata, A., Sai, J., Richmond, A. J., Garofalo, R., & Rajarathnam, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011754 · Cited by 121
Nanki, T., Takada, K., Komano, Y., Morio, T., Kanegane, H., Nakajima, A., Lipsky, P. E., & Miyasaka, N. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2823 · Cited by 121
Delgado, M., & Ganea, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-1029fje · Cited by 119
Pulmonary Chemokine Expression Is Coordinately Regulated by STAT1, STAT6, and IFN-γ
Fulkerson, P. C., Zimmermann, N., Hassman, L. M., Finkelman, F. D., & Rothenberg, M. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7565 · Cited by 119
Detection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain
Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 117
Nedjai, B., Hitman, G. A., Quillinan, N., Coughlan, R. J., Church, L. D., McDermott, M., & Turner, M. D. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24294 · Cited by 117
Self-citationDexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
Kurkowska-Jastrzębska, I., Litwin, T., Joniec, I., Ciesielska, A., Przybyłkowski, A., Członkowski, A., & Członkowska, A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.006 · Cited by 117
S100β Induction of the Proinflammatory Cytokine Interleukin‐6 in Neurons
Li, Y., Barger, S. W., Liu, L., Mrak, R. E., & Griffin, W. S. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740143.x · Cited by 117
Immunology and functional genomics of Behçet's disease
Zierhut, M., Mizuki, N., Ohno, S., Inoko, H., Gül, A., Onóe, K., & Isogai, E. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2333-3 · Cited by 117
The importance of shedding of membrane proteins for cytokine biology.
Müllberg, J., Althoff, K., Jostock, T., & Rose‐John, S. (2000) · PubMed · Cited by 116
Šimić, G., Lucassen, P. J., Krsnik, Ž., Krušlin, B., Kostović, I., Winblad, B. G., & Bogdanović, N. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7448 · Cited by 115
Aβ Internalization by Neurons and Glia
Mohamed, A., & Chaves, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/127984 · Cited by 113
Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease
Nishimura, M., Kuboi, Y., Muramoto, K., Kawano, T., & Imai, T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04738.x · Cited by 111
Hehlgans, T., & Männel, D. N. (2002) · Biological Chemistry · doi:10.1515/bc.2002.178 · Cited by 111
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung
Venge, J., Lampinen, M., Håkansson, L., Rak, S., & Venge, P. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70265-8 · Cited by 110
Anti-TNF Therapy, from Rationale to Standard of Care: What Lessons Has It Taught Us?
Feldmann, M., & Maini, R. N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1090051 · Cited by 108
Álvarez, G., Aldudo, J., Alonso, M., Santana, S., & Valdivieso, F. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23003 · Cited by 108
Smith, K. A., & Maizels, R. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343746 · Cited by 101
Gauldie, J., Richards, C. D., Northemann, W., et al. (1989) · PubMed · Cited by 100
Cited by
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143
Functional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Combination strategies to maximize the benefits of cancer immunotherapy
Zhu, S., Zhang, T., Zheng, L., Liu, H., Song, W., Liu, D., Li, Z., & Pan, C.-X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01164-5 · Cited by 654
Metadata
- Authors
- Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 1843
- Issue
- 11
- Pages
- 2563-2582
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2118742454
- Cited by
- 2,162
- References
- 277
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.